Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Duration Study
NCT00210730Phase 3Terminated
- Sponsor
- Johnson & Johnson
- Start
- Jun 2004
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Johnson & Johnson. Started Jun 2004; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00210730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210730.